Clinical Trials Browser

Withdrawn × OTHER × antineoplaston A10 × Clear all

NCT00003512 2018-02-05

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia

Phase 2 Withdrawn

Waldenstrom Macroglobulinemia

NCT00003534 2018-01-31

Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms

NCT01260103 2017-07-26

Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma

Phase 3 Withdrawn

Recurrence, Optic Nerve Glioma